AnaCardio
Series BStockholm, SwedenSep 2026
AnaCardio raised €63M in a Series B round in Sep 2026. The company is based in Stockholm, Sweden. Investors in the round: Flerie Invest, Helsinn Investment Fund, Industrifonden and 6 others. Data as of Nov 2026.
Amount raised
€63M
€62,500,000
Native amount
62,500,000 EUR
Stage
Series B
series b
Investors
9
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €63M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
9 namedFlerie InvestHelsinn Investment FundIndustrifondenInnovestor Life Science FundLjungström family officeLLD Nybohov Invest ABNovo HoldingsPureos BioventuresSound Bioventures
Date
Sep 2026
Round type
series b
Amount (EUR)
€63M